CHEFLOXACIN

This brand name is authorized in Nigeria.

Active ingredients

The drug CHEFLOXACIN contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0443	Tablet	CHEFLOXACIN TABLETS TAB 500 mg 1 X 10	82 CMS-PP-233207 CHEFLOXACIN TABLETS CIPROFLOXACIN 500mg CIPROFLOXACIN 500MG, CORNSTARCH, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE, CROSPOVIDONE, MAGNESIUM STEARATE B4-0443 Drugs Imported Products 1X10'S Prescription Only Medicine (POM) 8/22/2022 OCEAN PHARMACEUTICAL & ALLIED PRODUCTS LTD, EDOZIEN STREET KANO KANO 8099448946 oceanpharmltd2021@gmail.com AR LIFESCIENCES, 819/B, Rakanpur Industrial Area, Rakanpur-Santej Road, Ta. Kalol, Dist. Gandhinagar, India, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0443